Drug Safety Information for PLAN B ONE-STEP (Levonorgestrel)
Safety-related Labeling Changes for JADELLE (LEVONORGESTREL) Discontinued Drug: FDA Link
Safety-related Labeling Changes for PLAN B (LEVONORGESTREL) Rx Drug: FDA Link
Safety-related Labeling Changes for MIRENA (LEVONORGESTREL) Rx Drug: FDA Link
Safety-related Labeling Changes for PLAN B ONE-STEP (LEVONORGESTREL) Over-the-counter Drug: FDA Link
Safety-related Labeling Changes for SKYLA (LEVONORGESTREL) Rx Drug: FDA Link
Safety-related Labeling Changes for LILETTA (LEVONORGESTREL) Rx Drug: FDA Link
Adverse Drug Reactions for PLAN B ONE-STEP* (Levonorgestrel)
These charts and graphs are based on reports received through the FDA Adverse Event Reporting System (FAERS) program (see below).
Top 20 Adverse Effects Associated with PLAN B ONE-STEP
(reported in FDA Medwatch/FAERS Reports)
Side Effect | # of FDA Reports | |
---|---|---|
1 | Device expulsion | 25426 |
2 | Menstruation irregular* | 12896 |
3 | Device dislocation | 9022 |
4 | Abdominal pain | 5892 |
5 | Vaginal haemorrhage | 5617 |
6 | Pain* | 5320 |
7 | Uterine perforation | 4484 |
8 | Pelvic pain | 4439 |
9 | Nausea | 4351 |
10 | Abdominal pain lower | 4329 |
11 | Genital haemorrhage | 4327 |
12 | Injury | 4058 |
13 | Medical device complication | 4052 |
14 | Procedural pain | 3497 |
15 | Pregnancy with contraceptive device | 3324 |
16 | Amenorrhoea | 3099 |
17 | Emotional distress | 2837 |
18 | Headache* | 2783 |
19 | Menorrhagia | 2767 |
20 | Vomiting | 2440 |
* This side effect also appears in "Top 10 Side Effects of PLAN B ONE-STEP " in the drug's Review Summary based on AskaPatient reviews.
Top 10 Reasons for Taking PLAN B ONE-STEP
(associated with FDA Medwatch/FAERS Reports)
Reason | # of FDA Reports | |
---|---|---|
1 | Contraception* | 116759 |
2 | Post coital contraception | 40096 |
3 | Product used for unknown indication | 17425 |
4 | Menorrhagia* | 5216 |
5 | Endometriosis* | 1034 |
6 | Menstrual cycle management | 575 |
7 | Menstruation irregular | 535 |
8 | Vaginal haemorrhage | 453 |
9 | Menstrual disorder | 321 |
10 | Oral contraception | 301 |
*Also a top-10 reason in AskaPatient Review Summary.
Types of Adverse Events for PLAN B ONE-STEP
Total Reports Filed with FDA: 229779
Number of FDA Adverse Event Reports by Patient Age for PLAN B ONE-STEP
Total Reports Filed with FDA: 229779*
* Reports for drugs with the same active ingredients have been aggregated in this analysis: Levonorgestrel (Norlevo, Norplant ii, Next choice one dose, Fallback solo, Opcicon one-step, Liletta, Take action, Plan b, Mirena, My way, Skyla, Microval, Lutera, Next choice, Norgeston, Jadelle, Plan b one-step, Levonorgestrel, Norplant)
Charts are based on 229779 reports filed with the FDA between 2004 and June 2015.
Adverse Event Reports are submitted to the FDA by pharmaceutical companies (mandatory reporting is required by manufacturers, distributors, or importers), health care providers such as doctors (voluntary reporting), and by patients themselves (voluntary reporting). More Information on FDA MedWatch (FDA Safety Information and Adverse Event Reporting Program)Voluntary reporting takes place under the FDA's MedWatch program, where health care professionals and consumers submit reports to FDA when they find a problem with a drug, medical device, biologic, or other FDA-regulated product. An adverse event is any undesirable experience or extreme side effect associated with the use of a medical product. Adverse events include: death, life threatening event, hospitalization, disability or permanent damage, congenital anomaly or birth defect, medical product use requiring a surgical or other intervention, or other serious medical situation believed to be caused by the drug.
Click to go back to search results and PLAN B ONE-STEP Reviews and Review Summary .
Historical Analytics of FDA Adverse Event Reports Provided by Druginformer.com. FDA Drug Safety Information, including safety-related labeling updates, required post-approval safety studies, risk evaluation management strategies (REMS), alerts, and recalls are compiled by AskaPatient.com from the U.S. Food and Drug Administration.